A report from TheBusinessResearchCompany shows that the "Global Ovarian Cancer Drugs Market 2019" is expected to grow to $1.99 billion at a CAGR of 11.2% through 2022.

The Business Research Company’s Ovarian Cancer Drugs Global Market Report 2019 covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, ... Read more

Ovarian cancer is one of the most dreadful type of cancer widely found in women. In this cancer, abnormal cells growth is experienced in the ovaries, which has potential to invade or adversely affect other body parts such as abdomen layers, lining of the bowel and bladder, lymph nodes, and liver. Initial stages of ovarian cancer are associated with few vague symptoms, which further manifest as the cancer grows. These symptoms include inflating, pelvic ache, abdominal puffiness, and loss of ... Read more

Technavio has been monitoring the global ovarian cancer drugs market since 2014 and the market has grown steadily from a CAGR of 14% during 2013-2018, to an expected CAGR of over 22% during 2019-2023. The market is poised to grow by USD 2.68 billion during the forecast period.

“Increase in research to develop effective combination therapies is helping in the development of a strong pipeline. Researchers are developing effective combination therapies for disease ... Read more

Market Overview:
The global ovarian cancer drugs market is expected to reach a valuation of US$ 5.6 billion by 2022. This market is projected to grow at a steady CAGR of 8.4% during the forecast period of 2023-2030. Ovarian cancer drugs are crucial in the treatment of ovarian cancer, a common and aggressive form of cancer that affects women worldwide. These drugs offer several advantages, including targeted therapy, effective tumor ... Read more